Curative therapy for sickle cell disease (SCD) currently requires gonadotoxic conditioning
that can impair future fertility. Fertility outcomes after curative therapy are likely affected by …

There is an immediate need to address long‐standing questions about the reproductive
health of girls and women with sickle cell disease (SCD). There are many SCD‐related …

Assisted reproductive technologies (ART) are not yet systematically available to people with
sickle cell disease or their parents. Fertility care for these groups requires addressing sickle …

Women with sickle cell anemia (SCA) have higher rates of diminished ovarian reserve
(DOR) than age-matched controls. Pecker et al report a small study of patients with SCA that …

Sickle cell disease is the most common inherited pathological haemoglobinopathy. Over the
past 30 years, disease-related morbidity and mortality have improved in high-income …

Discussions regarding gonadal function and possible disease or treatment-related ovarian
or testicular dysfunction, sexual dysfunction, and possible future infertility can be challenging …

This review provides an overview of reproductive and sexual healthcare concerns for
individuals with SCD and their families. Reproductive and sexual health care are …

Background Both diagnosis and treatment of hemoglobinopathies have been associated
with an increased risk of fertility impairment. German guidelines recommend annual …

Background Sickle cell disease (SCD) is one of the most common inherited diseases
worldwide. It is associated with lifelong morbidity and a reduced life expectancy …

Objective To describe the prevalence of infertility and infertility treatment seeking among
people enrolled in the Sickle Cell Disease Implementation Consortium (SCDIC) registry and …